Publications

5674 Results

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study

Authors
GA Omura;MF Brady;KY Look;HE Averette;JE Delmore;HJ Long;S Wadler;G Spiegel;SG Arbuck
Journal / Conference
Journal of Clinical Oncology 21(15):2843-2848
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9238 (INT-0134) (GOG-134) (NCCTG-92-61-51)

Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin - a gynecologic Oncology Group Study

Authors
RC Young;MF Brady;RK Nieberg;HJ Long;AR Mayer;SS Lentz;J Hurteau;DS Alberts
Journal / Conference
Journal of Clinical Oncology 21(23):4350-4355
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9047 (GOG-95)

Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: melacine

Authors
VK Sondak;JA Sosman
Journal / Conference
Seminars in Cancer Biology 13(6):409-415
Year
2003
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003 PMID14528084

Authors
P Okunieff;RE Meyn;BA Teicher;CR Thomas, Jr.;LE Gaspar;D Raben;S Giri;RS Lavey;AT Turrisi;GP Swanson;SR Smalley
Journal / Conference
American Journal of Clinical Oncology 26(5):522-529
Year
2003
Research Committee(s)
Gastrointestinal, Head and Neck, and Lung
PMID
PMID14528084
Study Number(s)
S0004, S0023, S0304, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), S9908

A prospective randomized phase III trial of concurrent biochemotherapy (BCT) with cisplatin, vinblastine, dacarbazine (CVD), IL-2 and interferon alpha-2b (IFN) versus CVD alone in patients with metastatic melanoma (E3695): An ECOG-coordinated intergroup trial

Authors
MB Atkins;S Lee;LE Flaherty;J Sosman;V Sondak;JM Kirkwood
Journal / Conference
Proc Am Soc Clin Oncol 22:2003 (abstr 2847)
Year
2003
Research Committee(s)
Melanoma
Study Number(s)
E3695

Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? a Southwest Oncology Group study

Authors
CA Presant;J Jacobson;W Wolf;V Waluch;IC Weitz;JS Macdonald
Journal / Conference
Investigational New Drugs 20:369-376
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9006

Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study

Authors
GT Budd;C Rankin;LF Hutchins;L Wong;PJ Petruska;K Antman
Journal / Conference
Investigational New Drugs 20:129-132
Year
2002
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9518

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated Intergroup study

Authors
RE Martell;BL Peterson;HJ Cohen;WP Petros;KR Rai;VA Morrison;L Elias;L Shepherd;J Hines;RA Larson;CA Schiffer;HI Hurwitz
Journal / Conference
Cancer Chemotherapy and Pharmacology 50:37-45
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Overall results of a randomized trial of the Southwest Oncology Group

Authors
VK Sondak;PY Liu;RJ Tuthill;RA Kempf;JM Unger;JA Sosman;JA Thompson;GR Weiss;BG Redman;JG Jakowatz;RD Noyes;LE Flaherty
Journal / Conference
Journal of Clinical Oncology 20(8):2058-2066
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

PK1195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents, by more than one mechanism.

Authors
DE Banker;JJ Cooper;DA Fennell;CL Willman;FR Appelbaum;Cotter
Journal / Conference
Leukemia Research 26:91-106
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
S9617